ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer.

Cancer Med · 2015 · PMC4673991 · PMID 26275671

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

A borderline significant difference was detected for Hb level <10 g/dL and previous use of antithrombotic medications.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.